Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Israel / NCT07276334
Enrolling by invitation Not applicable

Same Day Discharge Vs. Hospitalization for Operative Fixation of Distal Radius Fractures

NCT07276334 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2026-01-01
Last updated
2026-01-15

Condition(s) studied

Distal Radius Fracture Fixation

Investigational drug(s) / intervention(s)

early release from hospitalDay after surgery release

early release from hospital: Same day discharge of patients undergoing distal radius operative fixation

Day after surgery release: release of patients one day after surgery

Study summary

The goal of this clinical trial is to examine the results for same-day discharge after distal radius operative fixation in adult pupolation. The main questions it aims to answer are:

Is same day discharge safe and effective for distal radius fractures? Are the functional and patient reported outcome measures results different between same day discharge and hospitalized patients? Researchers will compare same day discharge patients with jospitalized patients to see if there are any differences between the groups

Participants will:

* undergo surgery
* atend outpatient clinical follow up visits
* answer dedicated questioneres

Eligibility

Sex
ALL
Min age
18 Years
Max age
120 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged ≥18 years and * diagnosed with a DRF requiring surgical intervention and * booked for surgery Exclusion Criteria: * Refusal to participate in the study * lack of follow-up * incomplete clinical or radiologic documentation * significant cardiac or pulmonary comorbidities * inadequate social support at home

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shamir Medical Center Ẕerifin Israel

More Assaf-Harofeh Medical Center trials in Israel

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07276334 on ClinicalTrials.gov ↗ ← All trials in Israel